Disruption of Mitochondrial Respiration by Melatonin in MCF-7 Cells

• Published in: Toxicology and applied pharmacology 2001-03, Vol.171 (3), p.149-156
• Main Authors: Scott, Aaron E, Cosma, Gregory N, Frank, Anthony A, Wells, Robert L, Gardner, Henry S
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - metabolism; Adenocarcinoma - ultrastructure; Adenosine Triphosphate - metabolism; Antineoplastic agents; Antioxidants - pharmacology; Biological and medical sciences; Breast Neoplasms - metabolism; Breast Neoplasms - ultrastructure; Cell Respiration - drug effects; Chemotherapy; electron transport; Electron Transport Complex IV - metabolism; Female; GTP-Binding Proteins - metabolism; Humans; in vitro; Luminescent Measurements; MCF-7 cells; Medical sciences; melatonin; Melatonin - pharmacology; Microscopy, Electron; mitochondria; Mitochondria - drug effects; Mitochondria - metabolism; morphology; Oxygen Consumption - drug effects; Pharmacology. Drug treatments; Polarography; Receptors, Cell Surface - drug effects; Receptors, Cytoplasmic and Nuclear - drug effects; Receptors, Melatonin; Succinate Dehydrogenase - metabolism; Thymidine - metabolism; Tryptamines - pharmacology; Tumor Cells, Cultured
• ISSN: 0041-008X; 1096-0333
• DOI: 10.1006/taap.2000.9115

Clinical and laboratory studies have provided evidence of oncostatic activity by the pineal neurohormone melatonin. However, these studies have not elucidated its mechanism of action. The following series of MCF-7 breast tumor cell studies conducted in the absence of exogenous steroid hormones provide evidence for a novel mechanism of oncostatic activity by this endogenous hormone. We observed a 40–60% loss of MCF-7 cells after 20-h treatment with 100 nM melatonin, which confirmed and extended previous reports of its oncostatic potency. Interestingly, there were no observed changes in tritiated thymidine uptake, suggesting a lack of effect on cell cycle/nascent DNA synthesis. Further evidence of a cytocidal effect came from morphologic observations of acute cell death and autophagocytosis accompanied by degenerative changes in mitochondria. Studies of mitochondrial function via standard polarography revealed a significant increase in oxygen consumption in melatonin-treated MCF-7 cells. Enzyme-substrate studies of electron transport chain (complex IV) activity in detergent permeabilized cells demonstrated a concomitant 53% increase (p < 0.01) in cytochrome c oxidase activity. Additional studies of succinate dehydrogenase activity (complex II) as determined by reduction of (3-4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide demonstrated a significant increase (p < 0.05) in melatonin-treated cells and further confirmed the accelerated ET activity. Finally, there was a 64% decrease (p < 0.05) in cellular ATP levels in melatonin-treated cells. The G-protein-coupled melatonin receptor antagonist luzindole abrogated the cytotoxic and mitochondrial effects. These studies suggest a receptor-modulated pathway of cytotoxicity in melatonin-treated MCF-7 tumor cells with apparent uncoupling of oxidative phosphorylation.